(Q45195613)

10 December 2017

Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. (English)

1 reference

10 December 2017

0 references

0 references

McColley SA

1

1 reference

10 December 2017

Stellmach V

2

1 reference

10 December 2017

Boas SR

3

1 reference

10 December 2017

Jain M

4

1 reference

10 December 2017

Crawford SE

5

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

10 December 2017

1 reference

10 December 2017

161

1 reference

10 December 2017

6

1 reference

10 December 2017

1877-1880

1 reference

The incidence of cystic fibrosis.

10 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905022

The Risk of Cancer among Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905022

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905022

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905022

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905022

10.1164/AJRCCM.161.6.9905022

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference